ATE365915T1 - Modelle für ein skelettsystem - Google Patents

Modelle für ein skelettsystem

Info

Publication number
ATE365915T1
ATE365915T1 AT04767333T AT04767333T ATE365915T1 AT E365915 T1 ATE365915 T1 AT E365915T1 AT 04767333 T AT04767333 T AT 04767333T AT 04767333 T AT04767333 T AT 04767333T AT E365915 T1 ATE365915 T1 AT E365915T1
Authority
AT
Austria
Prior art keywords
models
osteoblasts
nodules
layer
deposited onto
Prior art date
Application number
AT04767333T
Other languages
English (en)
Inventor
Pierre Jurdic
Olivier Destaing
Frederic Saltel
Edith Bonnelye
Original Assignee
Centre Nat Rech Scient
Ecole Norm Superieure Lyon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0307025A external-priority patent/FR2855975B1/fr
Application filed by Centre Nat Rech Scient, Ecole Norm Superieure Lyon filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE365915T1 publication Critical patent/ATE365915T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/46—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Composite Materials (AREA)
  • Materials Engineering (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Prostheses (AREA)
AT04767333T 2003-06-11 2004-06-11 Modelle für ein skelettsystem ATE365915T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0307025A FR2855975B1 (fr) 2003-06-11 2003-06-11 Modeles de systeme osseux
FR0402993 2004-03-23

Publications (1)

Publication Number Publication Date
ATE365915T1 true ATE365915T1 (de) 2007-07-15

Family

ID=33554073

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04767333T ATE365915T1 (de) 2003-06-11 2004-06-11 Modelle für ein skelettsystem

Country Status (7)

Country Link
US (1) US20070065803A1 (de)
EP (1) EP1634072B1 (de)
AT (1) ATE365915T1 (de)
CA (1) CA2528766A1 (de)
DE (1) DE602004007267T2 (de)
ES (1) ES2289553T3 (de)
WO (1) WO2004111643A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110086080A1 (en) * 2007-11-14 2011-04-14 Osteosphere, Llc Ex-vivo production of human demineralized bone matrix
US8506982B2 (en) * 2007-11-14 2013-08-13 Osteosphere, Llc Development of a human colloidal bone graft material
WO2009064917A2 (en) * 2007-11-14 2009-05-22 Osteosphere, Llc Generation of an hla-negative osteogenic precursor cell line
CA2750605C (en) 2009-01-23 2019-01-22 Royal College Of Surgeons In Ireland Layered scaffold suitable for osteochondral repair

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485097A (en) * 1982-05-26 1984-11-27 Massachusetts Institute Of Technology Bone-equivalent and method for preparation thereof
US5719058A (en) * 1995-04-10 1998-02-17 Merck & Co., Inc. Method for producing a highly enriched population of osteoclast cells
CA2198978A1 (en) * 1996-03-01 1997-09-01 Clemens Antoni Van Blitterswijk Method for the in vitro production of bone
AU2001288743A1 (en) * 2000-09-05 2002-03-22 The Rockefeller University Osteoclast-associated receptor
WO2002072842A1 (en) * 2001-03-13 2002-09-19 Oscotec Inc. Transfected cell line which can be used for mass screening of the expression of osteoblast specific transcription factor runx2 and use thereof
US7025640B2 (en) * 2002-09-23 2006-04-11 Delphi Technologies, Inc. Circuit board inter-connection system and method

Also Published As

Publication number Publication date
WO2004111643A3 (fr) 2005-03-17
EP1634072A2 (de) 2006-03-15
DE602004007267T2 (de) 2008-02-28
US20070065803A1 (en) 2007-03-22
EP1634072B1 (de) 2007-06-27
WO2004111643A2 (fr) 2004-12-23
CA2528766A1 (fr) 2004-12-23
ES2289553T3 (es) 2008-02-01
DE602004007267D1 (de) 2007-08-09

Similar Documents

Publication Publication Date Title
DE602006017579D1 (de) Klebstoff für optischen film sowie von dem klebstoff gebrauch machendes klebevlies und optisches glied
CL2013002895A1 (es) Compuestos derivados de 7,8-dihidro-5h-pteridin-6-ona, utiles como intermediarios en la sintesis de compuestos derivados de pteridinona (divisional de la solicitud 3123-2005).
TW200730490A (en) Photoactive compounds
DE102005042403B8 (de) Modulares Sitzsystem für ein Fahrzeug
ATE448961T1 (de) Federungssystem für ein landwirtschaftliches fahrzeug
IL189499A0 (en) Diaminopyrimidines as p2x3 and p2x2/3 modulators
TW200613256A (en) Photoactive compounds
DE602005027299D1 (de) Kfz-Scheinwerfereinheit nach dem Projektionsprinzip
AP2182A (en) Invoice financing.
FR2881643B1 (fr) Composition matifiante comprenant de la perlite
DE502005007411D1 (de) Interferometrisches system für den einsatz von sonderoptiken
GB2426747B (en) Vehicle simulation system
DE602005003123D1 (de) Radaraltimeter für hängelasttransportierende helikopter
DE50303842D1 (de) Hilfsrahmen für Fahrzeuge
DE602006014866D1 (de) Elastisches polyurethangarn und verfahren zu seiner herstellung
ATE458767T1 (de) Metallfreie 1k-polyurethansysteme
ATE365915T1 (de) Modelle für ein skelettsystem
DE602004031804D1 (de) Befestigung für einen Faltenbalg.
DE602006014522D1 (de) Ligand für den vesikulären acetylcholintransporter
ITPR20040019A1 (it) Attrezzo da palestra per passare dalla sospensione all'appoggio.
GB2422447B (en) Dawn simulator
FIU20050101U0 (fi) Kulkuneuvon, kuten linja-auton, metrojunan tai vastaavan istuin
ATE538121T1 (de) 1,5,6-substituierte-2-oxo-3-cyano-1,6a- diazatetrahydrofluoranthene als antiinfektionsmittel
ATA18722003A (de) Vorderradaufhängung für ein zwei- oder dreirad
GB2422448B (en) Dawn simulator

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties